on 29 Nov 2024
Last Applicant/ Owned by
Astellas Pharma Inc.
5-1, Nihonbashi-Honcho 2 Chome,Chuo-KuTokyo 103-8411
JP
Serial Number
2308061 filed on 27th Nov 2023
Registration Number
TMA1273265 registered on 29th Nov 2024
Registration expiry Date
27th Nov 2033Correspondent Address
BROOKFIELD PLACE181 BAY STREET, SUITE 2100P.O. BOX 874TORONTO
ONTARIO
CA
M5J2T3
STYLIZED V DESIGN
Vienna Information
26 . 2 . 3
Sectors of circles or ellipses (except 26.2.7)Secteurs de cercle ou d'ellipse (excepté 26.2.7)
26 . 3 . 1
One triangleUn triangle
27 . 5 . 1
Letters presenting a special form of writingLettres présentant un graphisme spécial
27 . 5 . 8
Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.
27 . 5 . 21
One letterUne lettre
Trademark usage description
pharmaceutical product for the treatment of cancer.Classification Information
Class [005]
Pharmaceutical product for the treatment of cancer.
Classification kind code
12
Mark Details
Serial Number
2308061
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 42 on 11th Sep 2024 | Advertised |
| Submitted for opposition 27 on 14th Aug 2024 | Approval Notice Sent |
| Submitted for opposition 26 on 14th Aug 2024 | Approved |
| Submitted for opposition 22 on 06th Aug 2024 | Search Recorded |
| Submitted for opposition 48 on 19th Feb 2024 | Agent Changed |
| Submitted for opposition 257 on 01st Feb 2024 | Designation Notification - Madrid Protocol |
| Submitted for opposition 1 on 31st Jan 2024 | Created |
| Submitted for opposition 31 on 31st Jan 2024 | Formalized |
| Submitted for opposition 30 on 27th Nov 2023 | Filed |
| Submitted for opposition 228 on 27th Nov 2023 | International Registration |